CARDIOSAVE Hybrid and Rescue Intra-aortic Balloon Pumps (IABP) (Used to inflate and deflate intra-aortic balloons for temporary support of the left ventricle via the principle of counter-pulsation) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Maquet Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2016-RN-00265-1
  • 사례 위험등급
    Class I
  • 사례 시작날짜
    2016-03-15
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    Maquet has received reports that, in some cardiosave iabps, the scroll compressor did not meet the specifications for output pressure or vacuum at specific flow rates. when the scroll compressor fails, one of two high priority alarms will appear on the iabp display and patient therapy could be interrupted. the high priority alarms are “autofill failure” and “iab catheter restriction”. if either of the high priority alarms cannot be resolved, the event may be attributable to the scroll compressor failure and therapy to the patient cannot be manually restarted.In this situation and where supported by the iabp to stabilise their haemodynamic status, patients present with critical conditions (particularly those in transit), there is a risk for severe and possible irreversible injury.There are no complaints reported associated with a patient injury or death.
  • 조치
    Maquet is providing work around instructions for users to follow as an interim measure. A software upgrade will be installed as a permanent correction. An updated operator’s manual is being provided which includes additional important information regarding the configuration, alarms in the presence of ESI and self-checks for the compressor. Users are advised the units can continue to be used while the software is being implemented, however it is recommended that if available, they use an alternative unaffected device based on the individual benefit-risk assessment and particularly for patients in transit. If users choose to use an affected CARDIOSAVE IABP it is recommended that an alternative device is available for back-up.

Device

  • 모델명 / 제조번호(시리얼번호)
    CARDIOSAVE Hybrid and Rescue Intra-aortic Balloon Pumps (IABP) (Used to inflate and deflate intra-aortic balloons for temporary support of the left ventricle via the principle of counter-pulsation)Part Numbers: 0998-00-0800-XX and 0998-UC-0800-XXDistributed between 6 March 2012 to 20 October 2015ARTG Number: 118266
  • 의료기기 분류등급
  • Manufacturer

Manufacturer